Full Length Research Paper
References
|
Alexander KA, Warnick LD, Wiedmann M (2009). Antimicrobial resistant Salmonella in dairy cattle in the United States. Veterinary Research Communications 33(3):191-209. |
|
|
Bawer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disc method. American Journal of Clinical Pathology 45:493-496. |
|
|
Cantón E, Pemán J, Carrillo-Mu-oz A, Orero A, Ubeda P, Viudes A, Gobernado M (1999). Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards Method M27-A and two other methods. Journal of Clinical Microbiology 37(7):2197-2200. |
|
|
Galgiani JN, Reiser J, Brass C (1987). Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Journal of Antimicrobial Chemotherapy 31(9):1343-1347 |
|
|
Imran ZK, Al-Karrem ZA (2016a). Evaluation natural cloning of azole- resistant genes CDR1, CDR2, MDR and ERG11 between clinical and soil isolates of Candida albicans based on gene expression. International Journal of PharmTech Research 9(11):229-236. |
|
|
Imran ZK, Alshammry ZW (2016b). Molecular diagnosis of Candidemia of intensive care unit patients based on sequencing analysis of ITS regions. International Journal of PharmTech Research 9(12):658-668. |
|
|
Jetté LP, Sinave C (1999). Use of an oxacillin disc screening test for detection of penicillin and ceftriaxone-resistant pneumococci. Journal of clinical Microbiology 37(4):1178-1181. |
|
|
Jorgensen JH (1993). Selection criteria for an antimicrobial susceptibility testing system. Journal of Clinical Microbiology 31(11):2841-2844. |
|
|
Kirkpatrick WR, Turner TM, Fothergill AW, McCarthy DI, Redding SW, Rinaldi MG, Patterson TF(1998). Fluconazole disk diffusion susceptibility testing of Candida species. Journal of Clinical Microbiology 36(11):3429-3432 |
|
|
Lozono F, Szekely A, Johnson EM (1999). Comparison of a new commercial colorimetric micro dilution method with a standard method for in vitro susceptibility testing of Manual of Clinical Microbiology, page 18 7th editions. |
|
|
Mushi MF, Masewa B, Jande M, Mirambo MM, Mshana SE (2017). Prevalence and factors associated with over-the-counter use of antifungal agents in Mwanza City, Tanzania. Tanzania Journal of Health Research 19(1). |
|
|
National Committee for Clinical Laboratory Standards (NCCLS) 1995). Methodsfor Antifungal Disc Diffusion Susceptibility Testing of Yeasts: Approved Standard M44-A. NCCLS, Wayne, PA, USA. |
|
|
National Committee for Clinical Laboratory Standards (NCCLS) (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts- Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA. |
|
|
Rex JH, Pfaller MA, Galgiani JN (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework of in vitro-in vivocorrelation data for fluconazole, itraconazole, and Candida infections. Clinical Infectious Disease 24:235-247. |
|
|
Turnidge J, Paterson DL (2007). Setting and revising antibacterial susceptibility breakpoints. Clinical Microbiology Reviews 20(3):391-408. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
